Severe Services and Demanding Requirements | Equilibar

Severe Services and Demanding Requirements

Equilibar Back Pressure Regulators

Equilibar

 

Equilibar’s novel back pressure regulator and fluid control valve technology makes it an excellent solution in applications with severe services and demanding requirements. For more specific information about a demanding application, select one of the links below

Equilibar back pressure regulators can process multi-phase fluid flow while maintaining high precision.

Equilibar Research Series back pressure regulators offer flow control down below 0.001 ml/min.

Equilibar back pressure regulators are sensitive to 0.001 psig / 0.069 millibar(g) and can control to setpoints down to 0.02 psig / 1.38 millibar(g).

Our Research Series back pressure regulators are commonly used up to 10,000 psig / 690 bar(g).

Using Kalrez FFKM O-rings, Equilibar back pressure regulators can be used up to 300°C. Equilibar’s HT (High Temperature) Series back pressure regulators utilize a graphite seal for temperatures to 450°C at pressures up to 5000 psig / 344 bar(g).

Using HPLC tube fittings, our Research Series back pressure regulators have as little as 0.2 millilieter dead volume.

Equilibar offers products for use with the world’s most aggressive chemicals, featuring bodies of PTFE, Hastelloy C, titanium. Standard offerings feature Stainless Steel T316L.

Equilibar is proud to offer sanitary stainless steel valves and single use valves for use in BioPharma and other sanitary applications.

Gas

There are many ways that our back pressure regulators can be used to control gas pressure with precision.

Equilibar back pressure regulators can control the output pressure of virtually any pump.

Contact our application engineers to discuss your severe service requirements. In many cases, we are able to specify custom O-rings or diaphragms to meet your demanding requirements.

 

 

 

 

Equilibar News
PUK magazine cover with stainless steel device

Journal article focuses on oligonucleotide production using pressure control with built in dampener

Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic.  Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More

Read More